Unknown NA INTERVENTIONAL 2-arm NCT02982135

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study

Sponsor: liuxingju

Conditions Moyamoya Disease

Interventions bypass surgery and indrect bypass surgery

Updated 6 times since 2017 Last updated: Dec 2, 2016 Started: Jan 31, 2016 Primary completion: Dec 31, 2017 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Moyamoya Disease and is currently ongoing. liuxingju leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Dec 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Dec 2018 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

liuxingju

Data source: Ministry of Science and Technology of the People´s Republic of China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China